Published in
Wiley, British Journal of Haematology, 6(192), p. 1011-1014, 2020
DOI: 10.1111/bjh.16714
Links
Tools
Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma
Journal article published in 2020 by
Fulvio Massaro 
,
Yana Stepanishyna,
Martina Manni ,
Stefano Luminari,
Sara Galimberti,
Luigi Marcheselli,
Carlo Visco ,
Cristina Tecchio,
Caterina Stelitano,
Francesco Angrilli,
Mario Petrini,
Francesco Merli,
Massimo Federico
,
Yana Stepanishyna,
Martina Manni ,
Stefano Luminari,
Sara Galimberti,
Luigi Marcheselli,
Carlo Visco ,
Cristina Tecchio,
Caterina Stelitano,
Francesco Angrilli,
Mario Petrini,
Francesco Merli,
Massimo Federico
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 